ShanX Medtech vs Spotlight Pathology

ShanX Medtech vs Spotlight Pathology, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ShanX Medtech is on 55/100 and Spotlight Pathology on 42/100.

ShanX Medtech logo
ShanX MedtechDevelops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.
Try ShanX Medtech
Spotlight Pathology logo
Spotlight PathologyAI software for faster and more consistent identification of blood cancers.
Try Spotlight Pathology

Where each one leads

ShanX Medtech

  • our overall score: 55/100 against 42/100
  • domain rating: 18/100 against 14/100
  • headcount: 16 against 6
  • funding raised: $27.9M against $688K

Spotlight Pathology

  • agent readiness: 32/100 against 21/100

At a glance

MeasureShanX MedtechSpotlight Pathology
What it isDevelops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.AI software for faster and more consistent identification of blood cancers.
CategoryHealthTech, Biotechnology, Diagnostics, MedTechHealthTech, Artificial Intelligence, Biotechnology, Medical Devices
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware
Founded20192020
HeadquartersSan Diego, United StatesDaresbury, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureShanX MedtechSpotlight Pathology
Employees166
Total funding$27.9M$688K
Latest roundSeedSeed
LinkedIn followers2,416Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureShanX MedtechSpotlight Pathology
StartupHub scoreOur 0-100 rating55/10042/100
Traction50/10038/100
Team70/100Not published
Search visibility35/1006/100
Quality58/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)F (32/100)
Domain ratingLink authority, 0-10018/10014/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureShanX MedtechSpotlight Pathology
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksJquery, BootstrapNot detected

ShanX Medtech vs Spotlight Pathology: common questions

Which is better, ShanX Medtech or Spotlight Pathology?

On our 0-100 score ShanX Medtech rates higher (55/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do ShanX Medtech and Spotlight Pathology compare on the numbers?

ShanX Medtech leads on our overall score (55/100 against 42/100), domain rating (18/100 against 14/100), headcount (16 against 6), funding raised ($27.9M against $688K). Spotlight Pathology leads on agent readiness (32/100 against 21/100).

Read the full ShanX Medtech review and pricing or the Spotlight Pathology review and pricing. You can also browse other ShanX Medtech alternatives we track.